Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
J Immunol. 2011 Apr 1;186(7):4191-9. doi: 10.4049/jimmunol.1003674. Epub 2011 Feb 28.
Allogeneic hematopoietic cell transplantation has broad clinical applications extending from the treatment of malignancies to induction of immunologic tolerance. However, adaptive cellular and humoral immunity frequently remain impaired posttransplantation. Here, recovery of T-dependent and T-independent Ab responses was evaluated in mice transplanted with purified hematopoietic stem cells (HSCs) devoid of the mature immune cells believed to hasten immune recovery. Mixed and full donor chimeras were created by conditioning recipients with sublethal or lethal irradiation, respectively, across different donor/host genetic disparities. By 6 wk posttransplantation, all animals demonstrated robust T-independent Ab responses, and all mixed chimeras and recipients of MHC-matched or haploidentical HSCs with a shared MHC haplotype had T-dependent Ab responses equivalent to those of untransplanted controls. Full chimeras that received fully MHC-disparate HSCs showed delayed T-dependent Ab responses that recovered by 12 wk. This delay occurred despite early reconstitution and proper migration to germinal centers of donor-derived T(follicular helper) (T(FH)) cells. Congenic transplants into T(FH)-deficient CD4(-/-) mice revealed restoration of T-dependent Ab responses by 6 wk, leading us to conclude that MHC disparity caused delay in humoral recovery. These findings, together with our previous studies, show that, contrary to the view that depletion of graft lymphocytes results in poor posttransplant immunity, elimination of immune-suppressing graft-versus-host reactions permits superior immune reconstitution. This study also provides insight into the regeneration of T(FH) cells and humoral immunity after allogeneic HSC transplantation.
同种异体造血细胞移植具有广泛的临床应用,从治疗恶性肿瘤到诱导免疫耐受。然而,移植后适应性细胞和体液免疫通常仍然受损。在这里,评估了在移植缺乏被认为加速免疫恢复的成熟免疫细胞的纯化造血干细胞(HSCs)的小鼠中 T 依赖性和 T 非依赖性 Ab 反应的恢复。通过用亚致死或致死辐射分别对受者进行调理,在不同的供体/宿主遗传差异下创建混合和完全供体嵌合体。移植后 6 周,所有动物均表现出强大的 T 非依赖性 Ab 反应,所有混合嵌合体和接受 MHC 匹配或半同基因 HSCs(具有共享 MHC 单倍型)的受者的 T 依赖性 Ab 反应与未移植对照相当。接受完全 MHC 不匹配 HSCs 的完全嵌合体表现出延迟的 T 依赖性 Ab 反应,该反应在 12 周时恢复。尽管早期重建和供体来源的 T(滤泡辅助)(T(FH))细胞正确迁移到生发中心,但这种延迟仍会发生。将同基因移植到 T(FH)缺陷的 CD4(-/-)小鼠中,发现 T 依赖性 Ab 反应在 6 周时恢复,这使我们得出结论,MHC 差异导致体液恢复延迟。这些发现与我们之前的研究一起表明,与移植淋巴细胞耗竭导致移植后免疫不良的观点相反,消除免疫抑制的移植物抗宿主反应可实现更好的免疫重建。这项研究还为同种异体 HSC 移植后 T(FH)细胞和体液免疫的再生提供了深入的了解。